Maynard C, Fisher LD, Passamani ER.
Survival of black persons compared with white persons in the Coronary
Artery Surgical Study (CASS).
Am J Cardiol 1987;60:513-8.
Utilizing data from the Coronary Artery Surgical Study (CASS), a longitudinal
study of patients who underwent coronary angiography, the authors addressed
three main questions. First, the survival rate has been reported for the
entire patient group, but what is the survival rate for black patients
and how does it compare with the survival rate for white patients? Second,
it has been previously reported that black patients receive surgical treatment
less frequently than white patients, but does treatment affect the long–term
survival rate for black patients? Third, within treatment groups (surgical
and medical), does race predict longer survival? Subjects were enrolled
from July 1974 through May 1979 at 14 clinics in the United States and
one clinic in Canada. It is noteworthy that eight of the fourteen clinics
enrolled less than 20 black patients.
With regard to survival rates, the age-specific 5-year survival rate
was significantly lower for black men than for white men in two age groups:
the 40-44 year group and the 50-54 year group. There was also a statistical
trend of lower survival for black men in the 55-59 year, 60-64 year, and
65-69 year age groups. For women, only whites in the 50-54 year age group
had a survival advantage over blacks. The overall age- and sex-adjusted
survival was significantly higher for whites than blacks (88% of whites
survived 5 years compared with 82% of blacks, p<0.0001). When patients
were stratified by occupational group (professional, clerical, laborer,
homemaker, other), the 5-year survival was significantly different for
blacks and whites only in the laborer category (87% of whites and 80%
of blacks survived 5 years in this category, p=0.0002).
There was a trend for blacks to die of cardiac causes more frequently
than whites (85% of blacks versus 80% of whites, p=0.12). Among those
who died of non-cardiac deaths, blacks were slightly more likely to die
of atherosclerotic causes (8% versus 4.3%), and whites were slightly more
likely to die of non-atherosclerotic causes (14.6% versus 6.8%). There
were no statistically significant differences in specific causes of death,
but postoperative death within 30 days and cerebrovascular accidents were
slightly more frequent in blacks.
With regard to treatment effects, the authors divided the study group
into two categories, those who received surgical treatment (patients who
had coronary artery bypass grafting within a specified time) and those
who received medical treatment only (all others). After controlling for
other clinical and demographic predictors of survival, among patients
in the surgical group, the association between race and length of survival
was non-significant (p=0.279). Among patients in the medical group, black
patients had a higher mortality rate (p=0.0006).
In an assessment of black patients only, surgical treatment (versus medical
treatment only) was a significant predictor of survival even after controlling
for other known clinical and demographic predictors. Furthermore, only
30% of blacks who had severe disease (3-vessel or significant left main
CAD or left ventricular dysfunction) underwent coronary artery bypass
surgery. These data suggest that a group of black patients who were given
medical treatment only might have benefited from surgical therapy. In
the white group, the effect of surgical treatment on survival differed
according to clinical subtypes and was not presented. However, for both
black and white patients, other predictors included left ventricular wall
motion score, congestive heart failure, number of diseased vessels (interacting
with Canadian class for blacks), advanced age, cigarette smoking, and
a history of hypertension. A stratified survival analysis was done for
each of the most important predictors, and blacks had a lower survival
in almost all strata. Only in the group without angina was the survival
rate higher among blacks, but the difference was not statistically significant
(92% of blacks versus 89% of whites survived 5 years, p=0.0004). There
were no differences in survival for all categories of the congestive heart
failure score, for hypertensives, or for those who were not current smokers.
The authors note that previous reports based on data from this study
indicated that the blacks enrolled in CASS were characterized by high
levels of risk factors and minimal coronary artery disease (CAD). This
study showed that the black mortality rate in CASS was high when adjusted
for extent of CAD, and it appeared to be higher for blacks than for whites.
The under- utilization of surgical therapy for blacks might be a contributing
factor. The authors attempt to explain the racial difference in survival,
suggesting that “unmeasured factors may explain why black surgical
patients had better survival than their medical counterparts” and
listing such factors as “patient compliance, adequacy of medical
management and socioeconomic status.”